The role of metabolic syndrome in the development of polycystic ovary syndrome in adolescence

被引:0
作者
Avramenko, N. V. [1 ,2 ]
Kabachenko, O. V. [2 ]
Barkovskyi, D. Ye. [2 ]
Sierykh, K. V. [2 ]
机构
[1] Zaporizhzhia State Med & Pharmaceut Univ, Fac Postgrad Educ, Zaporizhia, Ukraine
[2] Zaporizhzhia State Med & Pharmaceut Univ, Fac Postgrad Educ, Dept Obstet Gynecol & Reprod Med, Zaporizhia, Ukraine
关键词
obesity; metabolic syndrome; polycystic ovary syndrome; adolescence; diagnosis; treatment; prevention; ASSOCIATIONS; MANAGEMENT; OBESITY; HEALTH; RISK;
D O I
10.14739/2310-1210.2023.3.251479
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The review article presents an analysis of the metabolic syndrome problem in children and adolescents, its role in the development of polycystic ovary syndrome (PCOS) in accordance with the latest International guidelines and modern literature. The urgency of the problem lies in the rapid spread of overweight among children in the world and, consequently, the growth of alimentary -de-pendent pathology. One of the major consequences of weight problems is metabolic syndrome (MS). There are still no clear MS criteria for children and adolescents. IDF suggests using IDF criteria for adults. Priority in the pathogenesis of MS is given to insulin resistance (IR), which is associated with puberty. The problem of IR assessment remains. HOMA-IR and QUICKI methods are not considered reliable tests to determine IR, so the assessment is based on clinical signs (hyperglycemia, dyslipidemia, abdominal obesity, hypertension). Obesity and IR can be predictors of PCOS, which can often be associated with puberty. Pathological signs of the syndrome ty-pical for adults in adolescence may be a manifestation of the physiological course of puberty. Obligative criteria for the diagnosis of PCOS in adolescence are irregular menstruation/oligomenorrhea, proven biochemically and clinically hyperandrogenemia). First-line therapy for PCOS in adolescents with MS is weight loss and dosed exercise, which helps to normalize a hormonal balance. Drug treatment may include insulin-sensitizing drugs (metformin), antiandrogens (spironlactone, flutamide, cyproterone acetate), 5-alpha-reductase inhibitors (finasteride), combined oral contraceptives, inositol. Prevention of overweight, obesity in children can prevent the development of IR and, accordingly, associated MS and PCOS, reproductive health disorders. Prevention measures are aimed at avoiding maternal obesity, gestational diabetes, malnutrition and smoking during pregnancy, promoting breastfeeding and physical activity.
引用
收藏
页码:255 / 261
页数:7
相关论文
共 42 条
[1]   Health Effects of Overweight and Obesity in 195 Countries over 25 Years [J].
Afshin, Ashkan ;
Forouzanfar, Mohammad H. ;
Reitsma, Marissa B. ;
Sur, Patrick ;
Estep, Kara ;
Lee, Alex ;
Marczak, Laurie ;
Mokdad, Ali H. ;
Moradi-Lakeh, Maziar ;
Naghavi, Mohsen ;
Salama, Joseph S. ;
Vos, Theo ;
Abate, Kalkidan H. ;
Abbafati, Cristiana ;
Ahmed, Muktar B. ;
Al-Aly, Ziyad ;
Alkerwi, Ala'a ;
Al-Raddadi, Rajaa ;
Amare, Azmeraw T. ;
Amberbir, Alemayehu ;
Amegah, Adeladza K. ;
Amini, Erfan ;
Amrock, Stephen M. ;
Anjana, Ranjit M. ;
Arnlov, Johan ;
Asayesh, Hamid ;
Banerjee, Amitava ;
Barac, Aleksandra ;
Baye, Estifanos ;
Bennett, Derrick A. ;
Beyene, Addisu S. ;
Biadgilign, Sibhatu ;
Biryukov, Stan ;
Bjertness, Espen ;
Boneya, Dube J. ;
Campos-Nonato, Ismael ;
Carrero, Juan J. ;
Cecilio, Pedro ;
Cercy, Kelly ;
Ciobanu, Liliana G. ;
Cornaby, Leslie ;
Damtew, Solomon A. ;
Dandona, Lalit ;
Dandona, Rakhi ;
Dharmaratne, Samath D. ;
Duncan, Bruce B. ;
Eshrati, Babak ;
Esteghamati, Alireza ;
Feigin, Valery L. ;
Fernandes, Joao C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (01) :13-27
[2]  
Antypkin Yu. H., 2021, ZDOROVIA UKRAINY, V1, P8
[3]   Modern aspects of management of patients with polycystic ovary syndrome [J].
Avramenko, N., V ;
Kabachenko, O., V ;
Barkovskyi, D. Ye ;
Sierykh, K., V .
ZAPOROZHYE MEDICAL JOURNAL, 2020, 22 (06) :865-873
[4]   Metabolic syndrome and insulin resistance in pre-pubertal children with psoriasis [J].
Caroppo, Francesca ;
Galderisi, Alfonso ;
Ventura, Laura ;
Fortina, Anna Belloni .
EUROPEAN JOURNAL OF PEDIATRICS, 2021, 180 (06) :1739-1745
[5]   Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies [J].
Cassar, Samantha ;
Misso, Marie L. ;
Hopkins, William G. ;
Shaw, Christopher S. ;
Teede, Helena J. ;
Stepto, Nigel K. .
HUMAN REPRODUCTION, 2016, 31 (11) :2619-2631
[6]   Association of puberty timing with type 2 diabetes: A systematic review and meta-analysis [J].
Cheng, Tuck Seng ;
Day, Felix R. ;
Lakshman, Rajalakshmi ;
Ong, Ken K. .
PLOS MEDICINE, 2020, 17 (01)
[7]   Geographical variation in the prevalence of obesity and metabolic syndrome among US adolescents [J].
DeBoer, M. D. ;
Filipp, S. L. ;
Gurka, M. J. .
PEDIATRIC OBESITY, 2019, 14 (04)
[8]   Risk of Ischemic Stroke Increases Over the Spectrum of Metabolic Syndrome Severity [J].
DeBoer, Mark D. ;
Filipp, Stephanie L. ;
Sims, Mario ;
Musani, Solomon K. ;
Gurka, Matthew J. .
STROKE, 2020, 51 (08) :2548-2552
[9]   Assessing and Managing the Metabolic Syndrome in Children and Adolescents [J].
DeBoer, Mark D. .
NUTRIENTS, 2019, 11 (08)
[10]   Metabolic Syndrome Severity and Risk of CKD and Worsened GFR: The Jackson Heart Study [J].
DeBoer, Mark D. ;
Filipp, Stephanie L. ;
Musani, Solomon K. ;
Sims, Mario ;
Okusa, Mark D. ;
Gurka, Matthew J. .
KIDNEY & BLOOD PRESSURE RESEARCH, 2018, 43 (02) :555-567